BioRestorative Therapies (BRTX) Stock Analysis: AI Score & Alternative Data
BRTX alt-data: sentiment climbing, headcount lagging
Is BioRestorative Therapies a buy right now? The alternative data says hold. This BRTX stock analysis is built on the 25+ alternative data signals AltIndex tracks on BioRestorative Therapies every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 47/100: a Hold. The stock trades at $2.29 with a $3M market cap.
The bullish side of the 90-day ledger: sentiment up 42.9% to 100/100. The drag: headcount (according to LinkedIn) down 15.0% to 17 employees. That tension is what keeps the score mid-range.
BRTX’s broader alt-data profile also covers web traffic (3K monthly visits), and Facebook followers (112). Every signal links to its own page with full history, the BRTX technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on BRTX is just below.
BioRestorative Therapies AI Stock Analysis
BioRestorative Therapies Inc. (stock symbol: BRTX) is a biotechnology company focused on developing stem cell-based therapies. Their primary areas of interest include chronic lumbar disc disease and metabolic disorders. The company's lead program, BRTX-100, is aimed at treating disc/spine disease by utilizing stem cells to regenerate damaged disc tissue.
Analysis generated October 2, 2026.
Recent BioRestorative Therapies Stock Alerts
|
BioRestorative Therapies | October 7 Price is down by -8.4% in the last 24h. |
|
BioRestorative Therapies | October 5 Price is up by 6.5% in the last 24h. |
|
BioRestorative Therapies | September 28 Price is down by -9.8% in the last 24h. |
|
BioRestorative Therapies | September 25 Price is up by 6.8% in the last 24h. |
BioRestorative Therapies Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 3K | 0.9% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 17 | 15.0% | |
| Employee Recommend | 0 | N/A | |
| Business Outlook | 0 | N/A | |
| Sentiment | 100 | 42.9% | |
| Reddit Mentions | 0 | N/A | |
| X Mentions | 14 | 366.7% | |
| Stocktwits Mentions | 2 | 84.6% | |
| News Mentions | 0 | N/A | |
| Stocktwits Subscribers | 4K | 1.9% | |
| Facebook Followers | 112 | 0% | |
| Facebook Engagement | 0 | N/A |
About BioRestorative Therapies (BRTX)
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols that primarily involve adult stem cells. The company is headquartered in Melville, New York.
| Price | $2.29 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $3M |
| Year Range | $2 – $33 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Biotechnology |
Latest BioRestorative Therapies News
View more →
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics PlatformJune 25 - GlobeNewswire |
|
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic GrowthJune 18 - GlobeNewswire |
|
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)May 27 - PRNewswire |
|
BioRestorative Completes Phase 2 Dosing of BRTX-100, Advancing Lead Regenerative Spine Program Toward 2027 Topline DataMay 26 - GlobeNewswire |
|
BioRestorative Therapies Presents New Preclinical Data at ISCT 2026 Highlighting Source-Specific Exosome Functionality and Commercial Applications in BioCosmeceuticalsMay 13 - GlobeNewswire |
|
See BioRestorative Therapies’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for BRTX, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEBioRestorative Therapies Earnings & Financial Performance
View all earnings →BioRestorative Therapies Insider Trading Activity
View all →| Broadrick Dale filed to sell 445,933 shares at $0.0. Oct 28 '24 |
| Silva Francisco filed to sell 155,759 shares at $0.0. Apr 9 '24 |
| Silva Francisco filed to sell 147,927 shares at $0.0. Apr 8 '24 |
| Silva Francisco filed to sell 149,159 shares at $0.0. Apr 8 '24 |
BioRestorative Therapies Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to BioRestorative Therapies
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Clearmind Medicine Common SharesCMND |
$6.42 9.9% | $3M | 38 |
 |
Jupiter NeurosciencesJUNS |
$2.80 2.1% | $3M | 48 |
 |
Matinas BioPharma HldgsMTNB |
$2.84 5.7% | $3M | 44 |
 |
Aptevo TherapeuticsAPVO |
$1.80 0.2% | $3M | 57 |
 |
Geovax LabsGOVX |
$0.29 1.1% | $3M | 46 |
Explore BioRestorative Therapies Data
Frequently Asked Questions: BioRestorative Therapies (BRTX)
BioRestorative Therapies has an AltIndex AI Score of 47/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.
47/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of BioRestorative Therapies (BRTX) stock is $2.29 with a market cap of $3M.
As of today, BioRestorative Therapies’s PE (Price to Earnings) ratio is —.
View the latest BioRestorative Therapies insider transactions to see recent buying and selling activity by company executives and directors.
Check the BioRestorative Therapies congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The BRTX stock price chart above shows BioRestorative Therapies’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full BioRestorative Therapies technical analysis for RSI, moving averages, and more.
See the stocks similar to BioRestorative Therapies section on this page for companies in the same industry ranked by market cap and AI Score.
